Full Archive

Mission Failure

(This post can be shared) Improving lives today and tomorrow by accelerating life-changing breakthroughs to cure, prevent and treat T1D and its complications- Mission JDRF To prevent and cure diabetes and to improve the lives of all people affected by diabetes. – Mission ADA An analysis of NHANES data from 2009-2020 suggest approximately 75% of people with diabetes in the US were not at the American Diabetes Association-recommended HbA1c target of less than...

Like sands through an hourglass

The textbook definition of insanity is repeating the same behavior and expecting a different result. In our wacky world we can amend that just a bit and say the textbook definition of insanity is allowing the same behavior and not giving a damn. This best describes what’s going on at Tandem these days. As the board of directors sit around doing nothing while the stock continues to hit new lows. This...

Cheap Protection

Can’t say we are at all shocked with Novo Nordisk announcement that they are buying a controlling stake in BIOCORP for $164.5 million. Biocorp has been around forever and has collaborated with Novo in the past. It also goes along with Novo’s conversion from an insulin first to GLP-1 first insulin second company. Give Novo some credit here for seeing the future. It’s just a matter of time before Tyler becomes...

A Non-Event

This morning Senseonics announced that UnitedHealthCare will begin covering the Eversense system. Shares of Senseonics which have been languishing are up almost 10% as investors foolishly believe this is going to make a difference. Here’s why it won’t. 1. The market has spoken, and patients prefer wearable not implantable systems. 2. Coverage has never been the problem as the company has been pretty good at getting the system covered. 3. Although we don’t...

A Non-Event

This morning Senseonics announced that UnitedHealthCare will begin covering the Eversense system. Shares of Senseonics which have been languishing are up almost 10% as investors foolishly believe this is going to make a difference. Here’s why it won’t. 1. The market has spoken, and patients prefer wearable not implantable systems. 2. Coverage has never been the problem as the company has been pretty good at getting the system covered. 3. Although we don’t...

Struggling to remain relevant.

One of the largest blunders in diabetes history was Teladoc buying Livongo for $19 Billion. This transaction occurred when digital health was hotter than Georgia asphalt. Thanks to COVID nearly every digital/virtual player was obtaining obscene valuations. Back then patients embraced digital/virtual options as they had no other choice. Back then we reminded everyone that if these companies were to survive over the long haul, they would need to prove...

Let’s pump it up.

Just when you think it’s safe to enter the water the music begins to play and the next thing you know that pesky shark shows ready for his afternoon meal. This is how the folks at Medtronic must feel. It seems they have already discovered a software issue with the brand-new way cool whiz bang 780G a system which is supposed to save the day. Sent to 780 patients last month...